Reaction
Which drugs are most reported with Respiratory syncytial virus infection?
As of the last recalculation, Respiratory Syncytial Virus Infection appears in 8,544 FAERS reports alongside 408 co-occurring drug terms. The strongest observed disproportionality signal is PALIVIZUMAB (PRR 442.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.